Evidence map›Paper›PMID 39402093›Full record

ArticleScientific reports2024

A mathematical model simulating the adaptive immune response in various vaccines and vaccination strategies.

Zhaobin Xu, Jian Song, Hongmei Zhang, Zhenlin Wei, Dongqing Wei, Guangyu Yang, Jacques Demongeot, Qiangcheng Zeng

Abstract read
In one paragraph

Article in Scientific reports, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Zhaobin XuDepartment of Life Science, Dezhou University, Dezhou, 253023, China. xuzhaobin@dzu.edu.cn.
Jian SongDepartment of Life Science, Dezhou University, Dezhou, 253023, China.
Hongmei ZhangDepartment of Life Science, Dezhou University, Dezhou, 253023, China.
Zhenlin WeiDepartment of Life Science, Dezhou University, Dezhou, 253023, China.
Dongqing WeiState Key Laboratory of Microbial Metabolism, Shanghai-Islamabad-Belgrade Joint Innovation Center on Antibacterial Resistances, Joint International Research Laboratory of Metabolic & Developmental Sciences, School of Life Sciences and Biotechnology, Shanghai Jiao Tong University, Shanghai, 200030, P. R. China.
Guangyu YangDepartment of Arts, Dezhou University, 253023, Dezhou, China.
Jacques DemongeotLaboratory AGEIS EA 7407, Team Tools for e-Gnosis Medical, Faculty of Medicine, University Grenoble Alpes (UGA), 38700, La Tronche, France. jacques.demongeot@univ-grenoble-alpes.fr.
Qiangcheng ZengDepartment of Life Science, Dezhou University, Dezhou, 253023, China. zengqiangcheng@126.com.

Funding

Dezhou University 30101418
6 · The paper itself

Abstract

Vaccination has been widely recognized as an effective measure for preventing infectious diseases. To facilitate quantitative research into the activation of adaptive immune responses in the human body by vaccines, it is important to develop an appropriate mathematical model, which can provide valuable guidance for vaccine development. In this study, we constructed a novel mathematical model to simulate the dynamics of antibody levels following vaccination, based on principles from immunology. Our model offers a concise and accurate representation of the kinetics of antibody response. We conducted a comparative analysis of antibody dynamics within the body after administering several common vaccines, including traditional inactivated vaccines, mRNA vaccines, and future attenuated vaccines based on defective interfering viral particles (DVG). Our findings suggest that booster shots play a crucial role in enhancing Immunoglobulin G (IgG) antibody levels, and we provide a detailed discussion on the advantages and disadvantages of different vaccine types. From a mathematical standpoint, our model proposes four essential approaches to guide vaccine design: enhancing antigenic T-cell immunogenicity, directing the production of high-affinity antibodies, reducing the rate of IgG decay, and lowering the peak level of vaccine antigen-antibody complexes. Our study contributes to the understanding of vaccine design and its application by explaining various phenomena and providing guidance in comprehending the interactions between antibodies and antigens during the immune process.

Indexed as

Adaptive ImmunityImmunoglobulin GVaccinationAntibodies, ViralHumansModels, TheoreticalT-LymphocytesVaccinesAntibodies, ViralImmunoglobulin GVaccinesAttenuated vaccineInactivated vaccineMathematical modelmRNA vaccineVaccination strategyVaccine designVirus-host interaction

Identifiers

PMID39402093
PMCPMC11473516

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.